Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

Robert F. Kennedy Jr. secures a prominent health role, pledging reform in vaccine approval. The FDA plans significant changes ...

Most vaccines -- and boosters -- are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease. But for respiratory diseases ...

JN.1 may not be more severe, but it spreads fast, and that’s reason enough to stay alert. Across Asia, the priority is clear: ...

WHO has presented a budget for the next two years that is 22% less than originally planned, largely in response to U.S. and ...

The imperfections and risks of older vaccines became more evident as first-hand experience of their benefits waned, and ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional ...

In the wake of President Trump's decision to withdraw from the World Health Organization, the agency is holding its first ...

Following the COVID-19 pandemic ... T-cell responses in the clinic as an off-the-shelf therapeutic cancer vaccine.” Future development of mRNA vaccines and therapeutics The mRNA vaccine and ...